Machina Capital’s Quest Diagnostics DGX Stock Holding History

Machina Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$859K	Buy	+4,054	New	+$796K	0.14%	207
2026 Q1	–	Sell	-10,613	Closed	-$1.84M	–	384
2025 Q4	$1.84M	Buy	+10,613	New	+$1.93M	0.35%	96
2024 Q3	–	Sell	-4,486	Closed	-$614K	–	300
2024 Q2	$614K	Sell	4,486 -3,880	-46%	-$531K	0.28%	134
2024 Q1	$1.11M	Buy	8,366 +4,252	+103%	+$552K	0.59%	52
2023 Q4	$567K	Sell	4,114 -3,066	-43%	-$403K	0.37%	105
2023 Q3	$875K	Buy	7,180 +3,399	+90%	+$453K	0.49%	70
2023 Q2	$531K	Buy	3,781 +3,673	+3,401%	+$506K	0.3%	139
2023 Q1	$15.3K	Buy	+108	New	+$15.5K	0.01%	402
2019 Q3	–	Sell	-1,710	Closed	-$173K	–	357
2019 Q2	$173K	Buy	+1,710	New	+$164K	0.06%	298

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Machina Capital's DGX Position: Q2 2026 in Review

Machina Capital opened a new position in Quest Diagnostics (DGX) in Q2 2026: 4,054 shares worth $859K. The stake represents 0.14% of the portfolio and ranks #207 among its holdings. This is a return to the name: Machina Capital previously reported a position in DGX as recently as Q4 2025.

Machina Capital first reported a position in DGX in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.84M in Q4 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Machina Capital held 4,054 shares of Quest Diagnostics worth $859K as of Q2 2026.
Quest Diagnostics was a new Machina Capital position in Q2 2026.
Quest Diagnostics made up 0.14% of Machina Capital's portfolio in Q2 2026, its #207 holding.
Machina Capital first reported a position in Quest Diagnostics in Q2 2019 and has held it in 9 quarters since.
Machina Capital's Quest Diagnostics position peaked at $1.84M in Q4 2025.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.